Stay updated on NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial
Sign up to get notified when there's something new on the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page.

Latest updates to the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference4%
- Check19 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes detected.SummaryDifference0.1%
- Check26 days agoNo Change Detected
- Check34 days agoChange DetectedVersion updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%
- Check41 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content.SummaryDifference0.2%
- Check48 days agoChange DetectedThe web page has updated its facility name and location details, while also revising the drug information available for Lisdexamfetamine Dimesylate and related topics. Additionally, the version number has been updated to v3.0.0.SummaryDifference5%
- Check62 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
Stay in the know with updates to NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NRP 104 Likeability & Safety in Stimulant Abuse Clinical Trial page.